Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Primary unilateral adrenal hyperplasia (PUAH) is a surgically-correctable form of primary (hyper) aldosteronism (PA) characterized by renin suppression, unilateral aldosterone hypersecretion, and moderate to severe hypertension secondary to hyperplasia of the adrenal gland.
Biomarker and diagnostic research for primary unilateral adrenal hyperplasia has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for primary unilateral adrenal hyperplasia.
49 publications have been identified in PubMed for primary unilateral adrenal hyperplasia. Research spans Case Report / Case Series (33%), Diagnostic / Biomarker (27%), and Review / Meta-Analysis (14%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 16 | 33% |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 1:07 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Testing and diagnosis research
13 |
27% |
Research summaries | 7 | 14% |
Clinical study results | 5 | 10% |
Laboratory research | 4 | 8% |
Disease patterns and progression | 4 | 8% |
Fayad M (2026). [PMID: 42103582](https://pubmed.ncbi.nlm.nih.gov/42103582/). *Ann Endocrinol (Paris)*. [Basic Science / Preclinical]
Mermejo LM (2026). [PMID: 42089263](https://pubmed.ncbi.nlm.nih.gov/42089263/). *J Clin Endocrinol Metab*. [Diagnostic / Biomarker]
Acharya AK (2026). [PMID: 42077577](https://pubmed.ncbi.nlm.nih.gov/42077577/). *World J Nucl Med*. [Diagnostic / Biomarker]
Sivarajan R (2026). [PMID: 42093047](https://pubmed.ncbi.nlm.nih.gov/42093047/). *J Med Case Rep*. [Case Report / Case Series]
Deng QR (2026). [PMID: 41962899](https://pubmed.ncbi.nlm.nih.gov/41962899/). *Endocr Pract*. [Diagnostic / Biomarker]
Ortiz-Flores AE (2026). [PMID: 42236016](https://pubmed.ncbi.nlm.nih.gov/42236016/). *Vitam Horm*. [Diagnostic / Biomarker]
Chu WK (2026). [PMID: 40804167](https://pubmed.ncbi.nlm.nih.gov/40804167/). *Hypertension research : official journal of the Japanese Society of Hypertension*. [Diagnostic / Biomarker]
Erickson LA (2026). [PMID: 41490755](https://pubmed.ncbi.nlm.nih.gov/41490755/). *Human pathology*. [Review / Meta-Analysis]
Wu CH (2026). [PMID: 41822958](https://pubmed.ncbi.nlm.nih.gov/41822958/). *Hypertension (Dallas, Tex. : 1979)*. [Case Report / Case Series]
Yüksek Acınıklı K (2026). [PMID: 38084047](https://pubmed.ncbi.nlm.nih.gov/38084047/). *Journal of clinical research in pediatric endocrinology*. [Basic Science / Preclinical]